Speciality: Oncology
Description:
A warm welcome to all the medical professionals in this interesting learning session on understanding the best treatment approaches of ALK positive lung cancer.
In this webinar, a panel discussion would take place involving Dr. Todd Bauer as the primary speaker and Dr. Ullas Batra as a moderator who will share the important facts associated with treatment approaches for management of ALK positive lung cancer.
Dr. Todd Bauer has explained all details associated with the incidence, progression and treatment of ALK positive lung cancer. Further, a discussion on all possible treatment approaches and their pros, cons are discussed.
ALK-positive lung cancer represents about 4% of lung cancer which generally appears in adenocarcinoma non-small cell lung cancer. Patients with ALK-positive are mostly younger than the average lung cancer patient and also do not have a smoking history compared to other lung cancers.
Therefore, you are going to have an overall knowledge regarding management of ALK positive lung cancer. Listen to the webinar, grab the knowledge that is shared and follow HiDoc for more such interesting webinar sessions.
See More Webinars @ Hidoc Webinars
1.
Primary Sjögren's syndrome patients' B-Cell Stimulating Factors are associated with the growth of lymphomas.
2.
The pandemic had little impact on mental health symptoms.
3.
Number of cancer survivors in the US reaches 18.6 million—projected to exceed 22 million by 2035
4.
Rising rates of head and neck cancers in England
5.
The hidden costs of cancer for young survivors are derailing their financial futures
1.
Interpreting Iron Studies: What Your Blood Results Really Mean
2.
Beating Cancer Fatigue The Most Effective Exercise Strategies for Breast Cancer Survivors
3.
How Parvovirus B19 Affects Pregnant Women and Their Unborn Babies
4.
Cardiotoxicity Beyond Anthracyclines: Redefining Risk in the Cardio-Oncology Era
5.
Fibroma: Understanding the Causes, Symptoms, and Treatment Options
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
The Evolving Landscape of First-Line Treatment for Urothelial Carcinoma
2.
Summary of The Impact of CDK4/6 Inhibition in HR+/HER2- Metastatic Breast Cancer: Insights from PALOMA-2
3.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia- Further Talks
4.
Key Takeaways from The CROWN Trial For ALK + NSCLC Patients with CNS Diseases
5.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VII
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation